[Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node]
- PMID: 26850667
[Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node]
Abstract
Objectives: To study the factors influencing the non-sentinel lymph node(NSLN) status and to assess performance of Memorial Sloan-Kettering Cancer Center (MSKCC) nomogram in predicting sentinel lymph node(SLN) metastases in a SLN positive Chinese breast cancer population.
Methods: Data were collected from breast cancer patients who were diagnosed with pathological positive sentinel lymph node and received further axillary lymph node dissection(ALND) in Shanghai Ruijin Hospital from January 2011 to August 2014. MSKCC nomogram was used to calculate each patient's NSLN metastasis risk score. The receiver operator characteristic curve (ROC curve) and the area under the ROC curve (AUC) was used to assess the predictive accuracy of the model.
Results: Among the 1 147 patients who received sentinel biopsy, 150 SLN positive patients who received ALND were enrolled in this study. By univariate analysis, multifocal breast cancer (χ(2)=5.887, P=0.015), SLN+ /SLN ratio (χ(2)=6.683, P=0.010) and abnormal axillary lymph node displayed by ultrasound (χ(2)=7.736, P=0.005) were the influencing factors of NSLN metastases. By multivariate analysis, multifocal breast cancer (OR=7.25, 95% CI: 1.73 to 30.43, P=0.007), SLN+ /SLN ratio ≥ 0.5 (OR=2.564, 95% CI: 1.22 to 5.39, P=0.013) and abnormal axillary lymph node displayed by ultrasound (OR=2.471, 95% CI: 1.18 to 5.19, P=0.017) were the independent influencing factors of NSLN metastases. The AUC of MSKCC nomogram in this population was 0.677.
Conclusions: For breast cancer patients with positive sentinel lymph node, multifocality, SLN+ /SLN ratio and axillary lymphadenopathy displayed by ultrasound is related to NSLN metastasis. MSKCC has low accuracy in predicting NSLN status of this population.
Similar articles
-
Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.Arch Surg. 2011 Sep;146(9):1035-40. doi: 10.1001/archsurg.2011.201. Arch Surg. 2011. PMID: 21931000
-
Assessment of an existing and modified model for predicting non sentinel lymph node metastasis in breast cancer patients with positive sentinel node biopsy.Gulf J Oncolog. 2013 Jan;1(13):15-22. Gulf J Oncolog. 2013. PMID: 23339977
-
Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.Int J Surg. 2013;11(7):538-43. doi: 10.1016/j.ijsu.2013.05.005. Epub 2013 May 22. Int J Surg. 2013. PMID: 23707626
-
Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system.Int J Clin Pract. 2008 Nov;62(11):1785-91. doi: 10.1111/j.1742-1241.2008.01887.x. Int J Clin Pract. 2008. PMID: 19143863 Review.
-
A quantitative analysis of tumour characteristics in breast cancer patients with extranodal extension in non-sentinel nodes.Breast. 2018 Apr;38:171-174. doi: 10.1016/j.breast.2018.01.003. Epub 2018 Feb 3. Breast. 2018. PMID: 29413405 Review.
Cited by
-
Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node.Medicine (Baltimore). 2019 Jan;98(1):e13916. doi: 10.1097/MD.0000000000013916. Medicine (Baltimore). 2019. PMID: 30608418 Free PMC article.
-
Establishment of Simple Nomograms for Predicting Axillary Lymph Node Involvement in Early Breast Cancer.Cancer Manag Res. 2020 Mar 18;12:2025-2035. doi: 10.2147/CMAR.S241641. eCollection 2020. Cancer Manag Res. 2020. PMID: 32256110 Free PMC article.
-
Validation of Breast Cancer Models for Predicting the Nonsentinel Lymph Node Metastasis After a Positive Sentinel Lymph Node Biopsy in a Chinese Population.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818785032. doi: 10.1177/1533033818785032. Technol Cancer Res Treat. 2018. PMID: 30033828 Free PMC article.
-
A new marker for predicting sentinel lymph node metastasis in early (cT1-2N0) breast cancer: Tumor-infiltrating lymphocytes (TILs).PLoS One. 2025 Mar 19;20(3):e0320487. doi: 10.1371/journal.pone.0320487. eCollection 2025. PLoS One. 2025. PMID: 40106761 Free PMC article.
-
Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients: A retrospective analysis.Front Oncol. 2023 Mar 10;13:1096589. doi: 10.3389/fonc.2023.1096589. eCollection 2023. Front Oncol. 2023. PMID: 36969057 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical